A Promising Biomarker for Pulmonary Sarcoidosis That Must Cross the Finish Line
- PMID: 38748223
- PMCID: PMC11506897
- DOI: 10.1164/rccm.202404-0750ED
A Promising Biomarker for Pulmonary Sarcoidosis That Must Cross the Finish Line
Comment on
-
Discovery of Two Novel Immunoepitopes and Development of a Peptide-based Sarcoidosis Immunoassay.Am J Respir Crit Care Med. 2024 Oct 1;210(7):908-918. doi: 10.1164/rccm.202306-1054OC. Am J Respir Crit Care Med. 2024. PMID: 38385694 Free PMC article.
References
-
- Jeny F, Bernaudin JF, Cohen Aubart F, Brillet PY, Bouvry D, Nunes H, et al. Diagnosis issues in sarcoidosis. Respir Med Res . 2020;77:37–45. - PubMed
-
- Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis . 2012;29:119–127. - PubMed
-
- Su R, Li MM, Bhakta NR, Solberg OD, Darnell EP, Ramstein J, et al. Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J . 2014;44:985–993. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
